{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:25:10Z","timestamp":1792121110108,"version":"4.4.0"},"reference-count":29,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi251399-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>The improvement of childhood cancer outcomes has relied on clinical trials, primarily from high-income countries (HICs). Inconsistent access to clinical trials, especially in low-income countries (LICs) and middle-income countries, contributes to disparate care and limits the generalizability of conclusions from trials conducted in HICs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251399-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To describe the global availability of clinical trials for children and adolescents with cancer in different economic settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251399-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>In this cross-sectional study, the World Health Organization\u2019s International Clinical Trials Registry Platform was used to search for clinical trials on May 8, 2024. Trials were included if they were interventional studies for pediatric patients (&amp;amp;lt;18 years old) with an active cancer diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251399-7\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Clinical trials were analyzed based on geographic location, World Bank country income classification, and trial characteristics, including study phase, sponsor type, intervention type, and inclusion criteria. The main outcome was differences between HICs and low- and middle-income countries in the availability, design, and results of clinical trials for children and adolescents with cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251399-8\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 138\u202f595 oncology trials, 5645 met the inclusion criteria. Of these, 3149 (55.8%) were pediatrics-only trials. Most pediatrics-only trials (2558 of 3149 [81.2%]) were conducted by sponsors in HICs. Among identified trials, 12.5% (394 of 3149) were open for accrual in upper-middle-income countries (UMICs), 8.9% (281 of 3149) in lower-middle-income countries (LMICs), and 0.2% (7 of 3149) in LICs. Compared with HICs, LMICs or LICs registered fewer early-phase trials (28.8% [42 of 146] vs 81.4% [1709 of 2100];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), trials with cancer-directed treatments (17.6% [46 of 262] vs 76.8% [1964 of 2558];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), and multi-institutional trials (6.5% [17 of 262] vs 54.2% [1386 of 2558];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). LMICs or LICs registered more supportive care\u2013based trials (81.7% [214 of 262] vs 19.9% [509 or 2558];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). Supportive care trials, later-phase trials, and trials from UMICs, LMICs, and LICs were more likely to publish clinical trial results within 10 years.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251399-9\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this cross-sectional study of global pediatric oncology clinical trials, low- and middle-income countries were underrepresented. These data illustrate the need to improve the clinical research infrastructure in low- and middle-income countries and foster inclusive collaborations to promote equity in global pediatric cancer clinical trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.52510","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T16:00:35Z","timestamp":1767715235000},"page":"e2552510","source":"Crossref","is-referenced-by-count":11,"title":["The Global Clinical Trial Landscape for Children and Adolescents With Cancer"],"prefix":"10.1001","volume":"9","author":[{"given":"Margit K.","family":"Mikkelsen","sequence":"first","affiliation":[{"name":"Department of Global Pediatric Medicine, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"},{"name":"Department of Oncology, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linh T. D.","family":"Pham","sequence":"additional","affiliation":[{"name":"Department of Global Pediatric Medicine, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catrian","family":"Sotelo","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology, Hospital de Pediatr\u00eda J.P. Garrahan, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mackenzie","family":"Kelley","sequence":"additional","affiliation":[{"name":"Eastern Virginia Medical School, Norfolk"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Edwards","sequence":"additional","affiliation":[{"name":"Center for Cancer and Blood Disorders, Children\u2019s Hospital of Colorado, Aurora"},{"name":"Department of Pediatrics, University of Colorado School of Medicine, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan R.","family":"Lion","sequence":"additional","affiliation":[{"name":"Department of Global Pediatric Medicine, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"},{"name":"Department of Oncology, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Ravi","sequence":"additional","affiliation":[{"name":"Center for Cancer and Blood Disorders, Children\u2019s Hospital of Colorado, Aurora"},{"name":"Department of Pediatrics, University of Colorado School of Medicine, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Chantada","sequence":"additional","affiliation":[{"name":"Pediatric Hemato-Oncology, Fundacion P\u00e9rez Scremini-Hospital Pereira Rossell, Montevideo, Uruguay"},{"name":"Oncology Department, Hospital Sant Joan de D\u00e9u, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"John T.","family":"Lucas","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giles W.","family":"Robinson","sequence":"additional","affiliation":[{"name":"Department of Oncology, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Santana","sequence":"additional","affiliation":[{"name":"Department of Global Pediatric Medicine, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"},{"name":"Department of Oncology, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Devidas","sequence":"additional","affiliation":[{"name":"Department of Global Pediatric Medicine, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Rodriguez-Galindo","sequence":"additional","affiliation":[{"name":"Department of Global Pediatric Medicine, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"},{"name":"Department of Oncology, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Moreira","sequence":"additional","affiliation":[{"name":"Department of Global Pediatric Medicine, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"},{"name":"Department of Oncology, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"issue":"5","key":"zoi251399r2","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1053\/j.seminoncol.2008.07.008","article-title":"Progress in childhood cancer: 50 years of research collaboration, a report from the Children\u2019s Oncology Group.","volume":"35","author":"O\u2019Leary","year":"2008","journal-title":"Semin Oncol"},{"issue":"1","key":"zoi251399r3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12939-018-0748-6","article-title":"Barriers for conducting clinical trials in developing countries\u2014a systematic review.","volume":"17","author":"Alemayehu","year":"2018","journal-title":"Int J Equity Health"},{"issue":"1","key":"zoi251399r4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1200\/JCO.2015.61.9148","article-title":"Global pediatric oncology: lessons from partnerships between high-income countries and low-to mid-income countries.","volume":"34","author":"Ribeiro","year":"2016","journal-title":"J Clin Oncol"},{"key":"zoi251399r5","doi-asserted-by":"publisher","DOI":"10.1200\/GO.24.00015","article-title":"Global equity in clinical trials: an ASCO policy statement.","volume":"10","author":"Al Sukhun","year":"2024","journal-title":"JCO Glob Oncol"},{"issue":"1","key":"zoi251399r6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/MOP.0b013e32835c1cbe","article-title":"Global challenges in pediatric oncology.","volume":"25","author":"Rodriguez-Galindo","year":"2013","journal-title":"Curr Opin Pediatr"},{"issue":"4","key":"zoi251399r7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S1470-2045(18)30909-4","article-title":"Estimating the total incidence of global childhood cancer: a simulation-based analysis.","volume":"20","author":"Ward","year":"2019","journal-title":"Lancet Oncol"},{"issue":"3","key":"zoi251399r8","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1016\/S1470-2045(13)70008-1","article-title":"Paediatric cancer in low-income and middle-income countries.","volume":"14","author":"Magrath","year":"2013","journal-title":"Lancet Oncol"},{"issue":"27","key":"zoi251399r9","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1200\/JCO.2014.60.6376","article-title":"Toward the cure of all children with cancer through collaborative efforts: pediatric oncology as a global challenge.","volume":"33","author":"Rodriguez-Galindo","year":"2015","journal-title":"J Clin Oncol"},{"issue":"4","key":"zoi251399r10","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.1016\/S1470-2045(20)30022-X","article-title":"Sustainable care for children with cancer: a Lancet Oncology Commission.","volume":"21","author":"Atun","year":"2020","journal-title":"Lancet Oncol"},{"key":"zoi251399r11","doi-asserted-by":"publisher","DOI":"10.1200\/GO.21.00266","article-title":"Mapping pediatric oncology clinical trial collaborative groups on the global stage.","volume":"8","author":"Major","year":"2022","journal-title":"JCO Glob Oncol"},{"issue":"3","key":"zoi251399r12","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/jamaoncol.2020.7478","article-title":"An analysis of contemporary oncology randomized clinical trials from low\/middle-income vs high-income countries.","volume":"7","author":"Wells","year":"2021","journal-title":"JAMA Oncol"},{"issue":"7","key":"zoi251399r13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003298","article-title":"Evidence for non-communicable diseases: analysis of Cochrane reviews and randomised trials by World Bank classification.","volume":"3","author":"Heneghan","year":"2013","journal-title":"BMJ Open"},{"key":"zoi251399r14","doi-asserted-by":"publisher","DOI":"10.1200\/GO.23.00379","article-title":"Lung cancer clinical trials in Latin America in the era of cooperative groups: a 20-year analysis.","volume":"10","author":"Knapp","year":"2024","journal-title":"JCO Glob Oncol"},{"issue":"7","key":"zoi251399r16","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/cncr.20910","article-title":"International Classification of Childhood Cancer, third edition.","volume":"103","author":"Steliarova-Foucher","year":"2005","journal-title":"Cancer"},{"issue":"9","key":"zoi251399r19","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1634\/theoncologist.2017-0122","article-title":"Perceptions of cancer care and clinical trials in the Black community: implications for care coordination between oncology and primary care teams.","volume":"22","author":"Sprague Martinez","year":"2017","journal-title":"Oncologist"},{"key":"zoi251399r21","first-page":"1","article-title":"Supportive care: low cost, high value.","volume":"41","author":"Popescu","year":"2021","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"4","key":"zoi251399r24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/archdischild-2019-318676","article-title":"Challenges in clinical trials for children and young people.","volume":"106","author":"Lagler","year":"2021","journal-title":"Arch Dis Child"},{"key":"zoi251399r26","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1228148","article-title":"The International Clinical Trials Registry Platform (ICTRP): data integrity and the trends in clinical trials, diseases, and drugs.","volume":"14","author":"Namiot","year":"2023","journal-title":"Front Pharmacol"},{"issue":"9438","key":"zoi251399r27","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0140-6736(04)17034-7","article-title":"Clinical trial registration: a statement from the International Committee of Medical Journal Editors.","volume":"364","author":"De Angelis","year":"2004","journal-title":"Lancet"},{"issue":"9","key":"zoi251399r28","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1056\/NEJMsa1012065","article-title":"The ClinicalTrials.gov results database\u2014update and key issues.","volume":"364","author":"Zarin","year":"2011","journal-title":"N Engl J Med"},{"issue":"5","key":"zoi251399r29","doi-asserted-by":"publisher","first-page":"e1269","DOI":"10.1542\/peds.2011-3565","article-title":"Status of the pediatric clinical trials enterprise: an analysis of the US ClinicalTrials.gov registry.","volume":"130","author":"Pasquali","year":"2012","journal-title":"Pediatrics"},{"key":"zoi251399r20","volume-title":"Protocol-Based Treatment for Children With Cancer in Low Income Countries in Latin America: A Report on the Recent Meetings of the Monza International School of Pediatric Hematology\/Oncology (MISPHO)\u2014Part II","author":"Howard","year":"2007"},{"key":"zoi251399r22","volume-title":"Ethical Conduct of Clinical Research Involving Children","author":"Field","year":"2004"},{"key":"zoi251399r1","unstructured":"CureAll framework: WHO global initiative for childhood cancer: increasing access, advancing quality, saving lives. World Health Organization. October 28, 2021. Accessed May 6, 2025. https:\/\/www.who.int\/publications\/i\/item\/9789240025271"},{"key":"zoi251399r15","unstructured":"About the WHO ICTRP. World Health Organization. 2024. Accessed May 6, 2025. https:\/\/www.who.int\/clinical-trials-registry-platform\/about"},{"key":"zoi251399r17","unstructured":"Hamadeh? N, Van Rompaey? C, Metreau? E, Eapen? SG. New World Bank country classification by income level: 2022-2023. World Bank. July 1, 2022. Accessed May 6, 2025. https:\/\/blogs.worldbank.org\/en\/opendata\/new-world-bank-country-classifications-income-level-2022-2023"},{"key":"zoi251399r18","unstructured":"Data and methods. International Agency for Research on Cancer. Accessed May 6, 2025. https:\/\/gco.iarc.who.int\/today\/en\/data-sources-methods#population-dictionary"},{"key":"zoi251399r23","unstructured":"Chantada? GL, Laub? T, Pritchard-Jones? K. SIOP\u2019s PARC Program: advancing research capacity for paediatric cancer clinical trials in low-resourced countries. International Society of Paediatric Oncology. Accessed May 6, 2025. https:\/\/siop-online.org\/wp-content\/uploads\/2022\/11\/60-65-Chantada.pdf"},{"key":"zoi251399r25","unstructured":"ICTRP Registry Network. World Health Organization. Accessed May 6, 2025. https:\/\/www.who.int\/tools\/clinical-trials-registry-platform\/network"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2843495\/mikkelsen_2026_oi_251399_1766526065.72345.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T16:00:37Z","timestamp":1767715237000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2843495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.52510","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]}}}